Clinical Trials Logo

Clinical Trial Summary

This phase II-III study will be randomized (2:1) patients starting first-line oral targeted therapies (OTT) for metastatic cancer between an individualized supervised physical exercise programs (SPEP) by a personal coach, and recommended physical exercises via a booklet. Eligible patients will have received ≤2 lines of metastatic chemotherapy, Eastern Cooperative Oncology Group Performance status (ECOG PS) ≤2, controlled pain (visual analogue scale (VAS) <3/10), and life expectancy ≥3 months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Home Based Standardised Adapted Physical Activity Programme
  • Neoplasm Metastasis
  • Patients Taking Oral Targeted Therapy for Metastatic Cancer

NCT number NCT03169075
Study type Interventional
Source UNICANCER
Contact
Status Active, not recruiting
Phase N/A
Start date July 11, 2017
Completion date July 11, 2028